tirzepatide and afib GLP-1 receptor agonists, including semaglutide (Wegovy/Ozempic) (Mounjaro/Zepbound), are being recognized for benefits beyond blood sugar control and weight management. New real-world evidence suggests they may also play a role in π§ Let's break the drug tirzepatide
Description
The treatment will feature compounded semaglutide, the same active ingredient in Novo Nordisk's blockbuster obesity and diabetes drugs Wegovy and Ozempic
Weight loss itself reduces AFib burden: studies demonstrate that losing 10% of body weight significantly decreases arrhythmia frequency and symptom severity in overweight AFib patients

Rated 5 out of 5 Anonymous (verified owner) I enjoy not having any symptoms that slow me down, also like that this includes the vitamin B12 Rated 5 out of 5 Andrew (verified owner) Love this stuff

Call to Action Not sure which option is right for you

Husain M, Birkenfeld AL, Donsmark M, Dungan K, Eliaschewitz FG, Franco DR, et al
